Literature DB >> 8064002

Interleukin 8 in Behçet's disease.

R Itoh1, T Takenaka, S Okitsu-Negishi, K Matsushima, M Mizoguchi.   

Abstract

Activated peripheral polymorphonuclear leukocytes (PMNs) and infiltration of PMNs into the lesions are characteristic findings of Behçet's disease (BD). A variety of cytokines, including interleukin 8 (IL-8), have been shown to activate PMNs. To investigate the role of IL-8 in the development of BD lesions, IL-8 production in vivo and in vitro was examined in 25 BD patients. IL-8 levels measured by ELISA in the non stimulated culture supernatants of peripheral mononuclear cells (MNCs) were higher in patients with active BD than in those with inactive BD or normal controls. Without LPS stimulation, IL-8 mRNA expression in incubated MNCs detected by Northern blot analysis was higher in active BD patients than in controls. Polarization assay confirmed the accelerated activity of PMN isolated from patients with active BD. However, these PMNs did not respond to IL-8 as strongly as to FMLP (an exogenous stimulator); a possible reason is that the PMNs of these patients are constantly exposed to IL-8 in vivo. Immunohistochemically, MNCs, endothelial cells and fibroblasts in BD lesions were positively stained by anti-IL-8 antibody. These data indicate that the production of IL-8 may be accelerated in inactive BD and that IL-8 may play an important role in the pathogenesis of BD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064002     DOI: 10.1111/j.1346-8138.1994.tb01762.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  10 in total

1.  Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Authors:  Sho Ueda; Mitsuteru Akahoshi; Atsunobu Takeda; Yasushi Inoue; Aya Omoto; Masahiro Ayano; Yasutaka Kimoto; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Hiroshi Tsukamoto; Takahiko Horiuchi; Shin-Ichi Hikita; Takako Fukuhara; Tatsuro Ishibashi; Koh-Hei Sonoda; Koichi Akashi
Journal:  Eur J Rheumatol       Date:  2018-03

2.  Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.

Authors:  Jing Shi; Xinxiang Huang; Guohua Li; Li Wang; Jinjing Liu; Yan Xu; Xiaofeng Zeng; Wenjie Zheng
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

Review 3.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

Review 4.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

5.  Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.

Authors:  Alzírton de Lira Freire; Manoel Barros Bertolo; Antônio José de Pinho; Adil Muhib Samara; Sandra Regina Muchinechi Fernandes
Journal:  Clin Rheumatol       Date:  2004-04-02       Impact factor: 2.980

6.  Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.

Authors:  Y Sumita; Y Murakawa; T Sugiura; Y Wada; A Nagai; S Yamaguchi
Journal:  Scand J Immunol       Date:  2012-06       Impact factor: 3.487

7.  Serum IL-17A in Behçet's disease.

Authors:  Nazan Emiroglu; Fatma Pelin Cengiz; Gul Bahar Erdem
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

8.  Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8.

Authors:  Hao Yin; Yun Song; Meimei Zheng; Ju Han; Jiyou Tang
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

9.  Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease.

Authors:  Won-Cheoul Jang; Yun-Hyoung Nam; Young-Chang Ahn; Sang-Hyun Lee; Sung-Hoon Park; Jung-Yoon Choe; Shin-Seok Lee; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2008-09-04       Impact factor: 3.580

10.  Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander T H Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2018-07-15       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.